Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
NCT ID: NCT02781623
Last Updated: 2022-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2015-10-31
2022-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
NCT01434966
MRI Morphology of Femoral Notch in ACL Injury
NCT06707285
EFFECT OF EARLY WEIGHT BEARING AND ACTIVE KNEE EXERCISES IN TREATMENT OF TIBIAL PLATEAU FRACTURES
NCT07251699
The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery
NCT03035266
Electromiographic Analysis of the Quadriceps After Trauma
NCT05574556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI
An MRI will be conducted pre-operatively, 3 months post-operatively, and 1 year post-operatively.
MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of tibial plateau fracture
* Patients who opt for surgical treatment or non-operative treatment of their fracture
* Patients who consent to undergoing 3 MRI scans
* Patients who are willing to follow-up for a minimum of 52 weeks
Exclusion Criteria
* Patients who may be pregnant or may become pregnant in the 52 weeks following injury
* Patients who have electric, magnetic, or mechanical devices currently implanted
* Patients who have abnormal ECG results
* Diagnosis of any additional lower extremity fractures other than tibial plateau
* Patients who fit the definition of a vulnerable population
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneeth Egol, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University Langone Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-00985
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.